MCID: DNN001
MIFTS: 47

Danon Disease

Categories: Genetic diseases, Rare diseases, Cardiovascular diseases, Neuronal diseases, Metabolic diseases

Aliases & Classifications for Danon Disease

MalaCards integrated aliases for Danon Disease:

Name: Danon Disease 53 12 49 24 55 71 36 28 13 51 14
Glycogen Storage Disease Type Iib 24 41 69
Pseudoglycogenosis Ii 53 12 71
Antopol Disease 53 12 49
Vacuolar Cardiomyopathy and Myopathy X-Linked 49 71
Glycogen Storage Disease Iib 53 71
Lysosomal Glycogen Storage Disease Without Acid Maltase Deficiency, Formerly 53
Lysosomal Glycogen Storage Disease with Normal Acid Maltase Activity 55
Lysosomal Glycogen Storage Disease Without Acid Maltase Deficiency 71
Lysosomal Glycogen Storage Disease with Normal Acid Maltase 24
Glycogen Storage Disease Due to Lamp-2 Deficiency 55
Vacuolar Cardiomyopathy and Myopathy, X-Linked 53
Glycogen Storage Disease Iib; Gsd2b, Formerly 53
Glycogen Storage Disease Limited to the Heart 49
X-Linked Vacuolar Cardiomyopathy and Myopathy 49
Glycogenosis Due to Lamp-2 Deficiency 55
Glycogen Storage Disease Type 2b 24
Glycogen Storage Cardiomyopathy 49
Gsd Due to Lamp-2 Deficiency 55
Pseudoglycogenosis 2 49
Gsd Iib, Formerly 53
Gsd2b, Formerly 53
Gsd-Iib 71
Gsd2b 71
Dand 71

Characteristics:

Orphanet epidemiological data:

55
glycogen storage disease due to lamp-2 deficiency
Inheritance: X-linked recessive; Prevalence: <1/1000000 (Worldwide),<1/1000000 (Sweden); Age of onset: Childhood; Age of death: adult;

OMIM:

53
Miscellaneous:
phenotypic variability
not all patients have skeletal muscle symptoms or mental retardation
sudden death in affected males occurs in teens
sudden death in affected females occurs in the forties
females often show milder phenotype with later onset of cardiac symptoms

Inheritance:
x-linked dominant


HPO:

31
danon disease:
Onset and clinical course phenotypic variability
Inheritance x-linked dominant inheritance


Classifications:



Summaries for Danon Disease

OMIM : 53 Danon disease is an X-linked dominant disorder predominantly affecting cardiac muscle. Skeletal muscle involvement and mental retardation are variable features. The accumulation of glycogen in muscle and lysosomes originally led to the classification of Danon disease as a variant of glycogen storage disease II (Pompe disease; 232300) with 'normal acid maltase' or alpha-glucosidase (GAA; 606800) (Danon et al., 1981). However, Nishino et al. (2000) stated that Danon disease is not a glycogen storage disease because glycogen is not always increased. Sugie et al. (2005) classified Danon disease as a form of autophagic vacuolar myopathy, characterized by intracytoplasmic autophagic vacuoles with sarcolemmal features. The characteristic vacuole is believed to be an autolysosome surrounded by secondarily-generated membranes containing sarcolemmal proteins, basal lamina, and acetylcholinesterase activity. X-linked myopathy with excessive autophagy (XMEA; 310440) is a distinct disorder with similar pathologic features. (300257)

MalaCards based summary : Danon Disease, also known as glycogen storage disease type iib, is related to myopathy, x-linked, with excessive autophagy and hypertrophic cardiomyopathy, and has symptoms including intellectual disability, gait disturbance and hypertrophic cardiomyopathy. An important gene associated with Danon Disease is LAMP2 (Lysosomal Associated Membrane Protein 2), and among its related pathways/superpathways is Lysosome. Affiliated tissues include heart, skeletal muscle and skin, and related phenotypes are Decreased viability and Decreased viability

Genetics Home Reference : 24 Danon disease is a condition characterized by weakening of the heart muscle (cardiomyopathy); weakening of the muscles used for movement, called skeletal muscles, (myopathy); and intellectual disability. Males with Danon disease usually develop the condition earlier than females and are more severely affected. Signs and symptoms begin in childhood or adolescence in most affected males and in early adulthood in most affected females. Affected males, on average, live to age 19, while affected females live to an average age of 34.

NIH Rare Diseases : 49 Danon disease is a rare genetic condition characterized by weakening of the heart muscle (cardiomyopathy), weakening of the muscles used for movement (skeletal muscles myopathy), and intellectual disability. This condition is a type of lysosomal storage disorder.Lysosomes are compartments within the cell that use enzymes to break down large molecules into smaller ones that the cell can use. In Danon disease there is a defect in the wall (membrane) of the lysosome. The defect is caused by mutations in the LAMP2 gene. Danon disease is inherited in an X-linked dominant pattern. As a result, males tend to be more severely affected than females and develop symptoms at a younger age. Treatment is aimed at addressing the symptoms present in each individual and may require a team of specialists.   Last updated: 7/12/2016

UniProtKB/Swiss-Prot : 71 Danon disease: DAND is a lysosomal glycogen storage disease characterized by the clinical triad of cardiomyopathy, vacuolar myopathy and mental retardation. It is often associated with an accumulation of glycogen in muscle and lysosomes.

Wikipedia : 72 Danon disease (or glycogen storage disease Type IIb) is a metabolic disorder.Danon disease is an... more...

Related Diseases for Danon Disease

Graphical network of the top 20 diseases related to Danon Disease:



Diseases related to Danon Disease

Symptoms & Phenotypes for Danon Disease

Symptoms via clinical synopsis from OMIM:

53
Cardiovascular Heart:
cardiomegaly
hypertrophic cardiomyopathy
wolff-parkinson-white syndrome
hypokinesia
dilated cardiomyopathy
more
Neurologic Central Nervous System:
cognitive impairment, mild
delayed development
mental retardation (70%)

Head And Neck Eyes:
moderate central loss of visual acuity in males (20/60)
normal to near-normal visual acuity in carrier females (20/30-20/20)
fine lamellar white opacities on slit lamp exam in carrier females
near complete loss of peripheral retinal pigment in males
peppered pigmentary mottling of peripheral retinal pigment in carrier females
more
Muscle Soft Tissue:
exercise intolerance
emg shows myopathic changes
severely decreased or absent lamp2 protein
proximal muscle weakness (85% of patients)
diffuse muscle atrophy
more
Laboratory Abnormalities:
increased serum creatine kinase

Skeletal Feet:
pes cavus (uncommon)


Clinical features from OMIM:

300257

Human phenotypes related to Danon Disease:

55 31 (show all 22)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 intellectual disability 55 31 very rare (1%) Very frequent (99-80%) HP:0001249
2 gait disturbance 55 31 hallmark (90%) Very frequent (99-80%) HP:0001288
3 hypertrophic cardiomyopathy 55 31 hallmark (90%) Very frequent (99-80%) HP:0001639
4 dilated cardiomyopathy 55 31 hallmark (90%) Very frequent (99-80%) HP:0001644
5 muscle flaccidity 55 31 hallmark (90%) Very frequent (99-80%) HP:0010547
6 cardiorespiratory arrest 55 31 hallmark (90%) Very frequent (99-80%) HP:0006543
7 global developmental delay 31 HP:0001263
8 visual impairment 31 HP:0000505
9 cognitive impairment 31 HP:0100543
10 cardiomegaly 31 HP:0001640
11 elevated serum creatine phosphokinase 31 HP:0003236
12 arrhythmia 31 HP:0011675
13 pes cavus 31 HP:0001761
14 wolff-parkinson-white syndrome 31 HP:0001716
15 hypokinesia 31 HP:0002375
16 exercise intolerance 31 HP:0003546
17 proximal muscle weakness 31 HP:0003701
18 generalized amyotrophy 31 HP:0003700
19 myocardial fibrosis 31 HP:0001685
20 myocardial necrosis 31 HP:0001700
21 exercise-induced muscle cramps 31 HP:0003710
22 emg 31 HP:0003458

GenomeRNAi Phenotypes related to Danon Disease according to GeneCards Suite gene sharing:

25
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased viability GR00221-A-1 9.58 MPP2 PIK3R4 PRKAG2
2 Decreased viability GR00221-A-2 9.58 MPP2 PIK3R4 PRKAG2
3 Decreased viability GR00221-A-3 9.58 MPP2 PIK3R4
4 Decreased viability GR00221-A-4 9.58 PIK3R4

Drugs & Therapeutics for Danon Disease

Search Clinical Trials , NIH Clinical Center for Danon Disease

Cochrane evidence based reviews: glycogen storage disease type iib

Genetic Tests for Danon Disease

Genetic tests related to Danon Disease:

# Genetic test Affiliating Genes
1 Danon Disease 28 LAMP2

Anatomical Context for Danon Disease

MalaCards organs/tissues related to Danon Disease:

38
Heart, Skeletal Muscle, Skin, Brain, Liver

Publications for Danon Disease

Articles related to Danon Disease:

(show top 50) (show all 104)
# Title Authors Year
1
Characteristics of induced pluripotent stem cells from clinically divergent female monozygotic twins with Danon disease. ( 29175505 )
2018
2
A Critical Evaluation of Liver Pathology in Humans with Danon Disease and Experimental Correlates in a Rat Model of LAMP-2 Deficiency. ( 28124283 )
2017
3
Transient Ischemic Attack and Ischemic Stroke in Danon Disease with Formation of Left Ventricular Apical Thrombus despite Normal Systolic Function. ( 29085695 )
2017
4
Heart transplantation in Danon disease: A single family displaying diverse phenotypes. ( 29153639 )
2017
5
Cardiac Danon disease: Insights and challenges. ( 28874294 )
2017
6
Psychiatric and cognitive characteristics of individuals with Danon disease (LAMP2 gene mutation). ( 28627787 )
2017
7
Malignant cardiac phenotypic expression of Danon disease (LAMP2 cardiomyopathy). ( 28874292 )
2017
8
Autophagy dysregulation in Danon disease. ( 28102838 )
2017
9
Danon disease for the cardiologist: case report and review of the literature. ( 28638575 )
2017
10
Impaired mitophagy facilitates mitochondrial damage in Danon disease. ( 28526246 )
2017
11
Heterogeneity in a large pedigree with Danon disease: Implications for pathogenesis and management. ( 28822614 )
2017
12
A rare phenotype of heterozygous Danon disease mimicking apical hypertrophic cardiomyopathy. ( 29240871 )
2017
13
Neuropsychological functioning following cardiac transplant in Danon disease. ( 28594253 )
2017
14
The c.65-2A>G splice site mutation is associated with a mild phenotype in Danon disease due to the transcription of normal LAMP2 mRNA. ( 26748608 )
2016
15
Early onset of cardiomyopathy and intellectual disability in a girl with Danon disease associated with a de novo novel mutation of the LAMP2 gene. ( 27145725 )
2016
16
Protein degradation in a LAMP-2-deficient B-lymphoblastoid cell line from a patient with Danon disease. ( 27130438 )
2016
17
Amelioration of X-Linked Related Autophagy Failure in Danon Disease With DNA Methylation Inhibitor. ( 27678261 )
2016
18
Lymphoma in Danon disease with chronic rhabdomyolysis treated with EPOCH-R: A case report. ( 27442649 )
2016
19
Cardiac arrhythmias in patients with Danon disease. ( 27742774 )
2016
20
Hypertrophic Cardiomyopathy with Unusual Extensive Scarring Pattern: Danon Disease. ( 28289499 )
2016
21
Danon disease - dysregulation of autophagy in a multisystem disorder with cardiomyopathy. ( 27165304 )
2016
22
Ischemic stroke due to hypoperfusion in a patient with a previously unrecognized Danon disease. ( 27816333 )
2016
23
Identification of LAMP2 Mutations in Early-Onset Danon Disease With Hypertrophic Cardiomyopathy by Targeted Next-Generation Sequencing. ( 27460667 )
2016
24
Identification of Two Novel LAMP2 Gene Mutations in Danon Disease. ( 27179547 )
2016
25
Severe left ventricular hypertrophy and marked cardiac fibrosis in Danon disease. ( 27395820 )
2016
26
A novel LAMP2 mutation associated with severe cardiac hypertrophy and microvascular remodeling in a female with Danon disease: a case report and literature review. ( 27497751 )
2016
27
LAMP2 flow cytometry in peripheral white blood cells is an established method that facilitates identification of heterozygous Danon disease female patients and mosaic mutation carriers. ( 25636828 )
2015
28
Danon disease: a phenotypic expression of LAMP-2 deficiency. ( 25589223 )
2015
29
Danon disease and a new mutation of the LAMP-2 gene in a Spanish family. ( 26385016 )
2015
30
Early onset cardiomyopathy in females with Danon disease. ( 25900304 )
2015
31
LAMP-2 deficiency leads to hippocampal dysfunction but normal clearance of neuronal substrates of chaperone-mediated autophagy in a mouse model for Danon disease. ( 25637286 )
2015
32
Oxidative Stress Mediates Cardiomyocyte Apoptosis in a Human Model of Danon Disease and Heart Failure. ( 25826782 )
2015
33
THE PHYSIOLOGY OF THE RETINAL PIGMENT EPITHELIUM IN DANON DISEASE. ( 26398689 )
2015
34
Danon disease: a rare cause of left ventricular hypertrophy with cardiac magnetic resonance follow-up. ( 26206213 )
2015
35
Asymptomatic young man with Danon disease. ( 24955057 )
2014
36
Danon disease: clinical features, evaluation, and management. ( 25228319 )
2014
37
Early diagnosis of Danon disease: Flow cytometric detection of lysosome-associated membrane protein-2-negative leukocytes. ( 25458169 )
2014
38
Novel LAMP2 mutations in Chinese patients with Danon disease cause varying degrees of clinical severity. ( 24691104 )
2014
39
Mosaic tissue distribution of the tandem duplication of LAMP2 exons 4 and 5 demonstrates the limits of Danon disease cellular and molecular diagnostics. ( 23716275 )
2014
40
Cystoid macular edema in a patient with Danon disease. ( 23571262 )
2013
41
Consider Danon disease in dilated cardiomyopathy with noncompaction. ( 23653338 )
2013
42
Morphologic and clinical aspects of Danon disease in a patient with a mutation c.137G > A in the LAMP-2 gene. ( 23504560 )
2013
43
Danon Disease Due to a Novel LAMP2 Microduplication. ( 24222494 )
2013
44
Late profound muscle weakness following heart transplantation due to Danon disease. ( 23168931 )
2013
45
Danon disease : A novel mutation in the LAMP-2 gene and ophthalmic abnormality. ( 23955649 )
2013
46
Lysosomal storage and advanced senescence in the brain of LAMP-2-deficient Danon disease. ( 23262972 )
2013
47
Danon disease as a cause of concentric left ventricular hypertrophy in patients who underwent endomyocardial biopsy. ( 22108829 )
2012
48
Sudden death associated with danon disease in women. ( 22074992 )
2012
49
A phenocopy of sarcomeric hypertrophic cardiomyopathy: LAMP2 cardiomyopathy (Danon disease) from China. ( 22187509 )
2012
50
Danon disease caused by two novel mutations of the LAMP2 gene: implications for two ends of the clinical spectrum. ( 22541782 )
2012

Variations for Danon Disease

UniProtKB/Swiss-Prot genetic disease variations for Danon Disease:

71
# Symbol AA change Variation ID SNP ID
1 LAMP2 p.Trp321Arg VAR_026230 rs104894859

ClinVar genetic disease variations for Danon Disease:

6 (show all 43)
# Gene Variation Type Significance SNP ID Assembly Location
1 LAMP2 NM_001122606.1(LAMP2): c.520C> T (p.Gln174Ter) single nucleotide variant Pathogenic rs104894857 GRCh38 Chromosome X, 120449006: 120449006
2 LAMP2 LAMP2, 2-BP DEL, 1097AA deletion Pathogenic
3 LAMP2 NM_001122606.1(LAMP2): c.440T> A (p.Leu147Ter) single nucleotide variant Pathogenic rs137852527 GRCh37 Chromosome X, 119582941: 119582941
4 LAMP2 LAMP2, IVS6, G-C, +5 single nucleotide variant Pathogenic
5 LAMP2 LAMP2, 1-BP INS, 974A insertion Pathogenic
6 LAMP2 LAMP2, IVS5, G-A, +1 single nucleotide variant Pathogenic
7 LAMP2 LAMP2, 1-BP DEL, 14G deletion Pathogenic
8 LAMP2 LAMP2, 1-BP INS, 883T insertion Pathogenic
9 LAMP2 LAMP2, 7-BP DEL deletion Pathogenic
10 LAMP2 NM_002294.2(LAMP2): c.928G> A (p.Val310Ile) single nucleotide variant Pathogenic rs104894858 GRCh37 Chromosome X, 119576454: 119576454
11 LAMP2 NM_001122606.1(LAMP2): c.961T> C (p.Trp321Arg) single nucleotide variant Pathogenic rs104894859 GRCh37 Chromosome X, 119575717: 119575717
12 LAMP2 LAMP2, 1-BP DEL, 1219A deletion Pathogenic
13 LAMP2 NM_002294.2(LAMP2): c.463delA (p.Ser155Valfs) deletion Likely pathogenic rs193922649 GRCh37 Chromosome X, 119582918: 119582918
14 LAMP2 NM_001122606.1(LAMP2): c.183T> A (p.Tyr61Ter) single nucleotide variant Likely pathogenic rs397516736 GRCh37 Chromosome X, 119590506: 119590506
15 LAMP2 NM_001122606.1(LAMP2): c.183T> G (p.Tyr61Ter) single nucleotide variant Likely pathogenic rs397516736 GRCh37 Chromosome X, 119590506: 119590506
16 LAMP2 NM_001122606.1(LAMP2): c.191delT (p.Val64Glufs) deletion Likely pathogenic rs397516738 GRCh37 Chromosome X, 119589418: 119589418
17 LAMP2 NM_002294.2(LAMP2): c.217_218insA (p.Thr73Asnfs) insertion Likely pathogenic rs397516739 GRCh37 Chromosome X, 119589392: 119589392
18 LAMP2 NM_002294.2(LAMP2): c.293G> A (p.Trp98Ter) single nucleotide variant Pathogenic rs397516740 GRCh37 Chromosome X, 119589316: 119589316
19 LAMP2 NM_002294.2(LAMP2): c.65-2A> G single nucleotide variant Pathogenic rs397516743 GRCh37 Chromosome X, 119590626: 119590626
20 LAMP2 NM_002294.2(LAMP2): c.864+3_864+6delGAGT deletion Pathogenic/Likely pathogenic rs397516751 GRCh37 Chromosome X, 119580154: 119580157
21 LAMP2 NM_002294.2(LAMP2): c.865-1G> C single nucleotide variant Likely pathogenic rs397516752 GRCh37 Chromosome X, 119576518: 119576518
22 LAMP2 NM_002294.2(LAMP2): c.1093+1G> A single nucleotide variant Pathogenic rs727504742 GRCh38 Chromosome X, 120441729: 120441729
23 LAMP2 NM_002294.2(LAMP2): c.999delA (p.Glu334Serfs) deletion Likely pathogenic rs727504557 GRCh38 Chromosome X, 120441824: 120441824
24 LAMP2 NM_002294.2(LAMP2): c.877C> T (p.Arg293Ter) single nucleotide variant Pathogenic rs727503118 GRCh37 Chromosome X, 119576505: 119576505
25 LAMP2 NM_002294.2(LAMP2): c.851_852delTT (p.Phe284Cysfs) deletion Pathogenic rs727504648 GRCh37 Chromosome X, 119580172: 119580173
26 LAMP2 NM_002294.2(LAMP2): c.183+1G> A single nucleotide variant Pathogenic/Likely pathogenic rs727503120 GRCh37 Chromosome X, 119590505: 119590505
27 LAMP2 NM_002294.2(LAMP2): c.1020delT (p.Gly341Glufs) deletion Pathogenic rs727504597 GRCh37 Chromosome X, 119575658: 119575658
28 LAMP2 NM_002294.2(LAMP2): c.929-1G> A single nucleotide variant Likely pathogenic rs727504262 GRCh37 Chromosome X, 119575750: 119575750
29 LAMP2 NM_002294.2(LAMP2): c.864+1G> T single nucleotide variant Pathogenic rs727503119 GRCh37 Chromosome X, 119580159: 119580159
30 LAMP2 NM_002294.2(LAMP2): c.121delT (p.Cys41Alafs) deletion Pathogenic rs727504600 GRCh38 Chromosome X, 120456713: 120456713
31 LAMP2 NC_000023.11: g.(?_120431323)_(120441894_?)del deletion Likely pathogenic GRCh37 Chromosome X, 119565178: 119575749
32 LAMP2 NM_002294.2(LAMP2): c.128_129dupAT (p.Ala44Metfs) duplication Likely pathogenic rs730880344 GRCh37 Chromosome X, 119590560: 119590561
33 LAMP2 NM_002294.2(LAMP2): c.795C> A (p.Cys265Ter) single nucleotide variant Pathogenic/Likely pathogenic rs730880483 GRCh37 Chromosome X, 119580229: 119580229
34 LAMP2 NM_002294.2(LAMP2): c.588_589insCAACA (p.Val197Glnfs) insertion Pathogenic rs730880492 GRCh38 Chromosome X, 120447993: 120447994
35 LAMP2 NM_002294.2(LAMP2): c.(?_398)-60_(741_?)+68del deletion Likely pathogenic GRCh38 Chromosome X, 120447773: 120449188
36 LAMP2 NM_002294.2(LAMP2): c.912T> G (p.Tyr304Ter) single nucleotide variant Likely pathogenic rs876657648 GRCh38 Chromosome X, 120442615: 120442615
37 LAMP2 NM_002294.2(LAMP2): c.294G> A (p.Trp98Ter) single nucleotide variant Pathogenic rs876657696 GRCh38 Chromosome X, 120455460: 120455460
38 LAMP2 NM_002294.2(LAMP2): c.962G> A (p.Trp321Ter) single nucleotide variant Pathogenic rs1060502306 GRCh38 Chromosome X, 120441861: 120441861
39 LAMP2 NM_002294.2(LAMP2): c.1013C> G (p.Ser338Ter) single nucleotide variant Pathogenic rs1060502305 GRCh38 Chromosome X, 120441810: 120441810
40 LAMP2 NM_002294.2(LAMP2): c.788delG (p.Gly263Alafs) deletion Pathogenic rs1060502303 GRCh38 Chromosome X, 120446381: 120446381
41 LAMP2 NM_001122606.1(LAMP2): c.546_548delGAGinsTA (p.Ser183Thrfs) indel Pathogenic rs1060502302 GRCh38 Chromosome X, 120448978: 120448980
42 LAMP2 NM_002294.2(LAMP2): c.973dupC (p.Leu325Profs) duplication Pathogenic GRCh38 Chromosome X, 120441850: 120441850
43 LAMP2 NM_002294.2(LAMP2): c.696T> A (p.Cys232Ter) single nucleotide variant Pathogenic GRCh37 Chromosome X, 119581741: 119581741

Expression for Danon Disease

Search GEO for disease gene expression data for Danon Disease.

Pathways for Danon Disease

Pathways related to Danon Disease according to KEGG:

36
# Name Kegg Source Accession
1 Lysosome hsa04142

Pathways related to Danon Disease according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 10.71 GAA LAMP2

GO Terms for Danon Disease

Cellular components related to Danon Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 endosome GO:0005768 9.61 LAMP2 PIK3R4 VPS4A
2 late endosome membrane GO:0031902 9.4 LAMP2 VPS4A
3 lysosomal lumen GO:0043202 9.37 GAA LAMP2
4 phagocytic vesicle membrane GO:0030670 9.32 LAMP2 PIK3R4
5 ficolin-1-rich granule membrane GO:0101003 9.26 GAA LAMP2
6 azurophil granule membrane GO:0035577 9.16 GAA LAMP2
7 late endosome GO:0005770 9.13 LAMP2 PIK3R4 VPS4A
8 lysosome GO:0005764 8.92 GAA LAMP2 VMA21 VPS4A

Biological processes related to Danon Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 glycogen metabolic process GO:0005977 9.16 GAA PRKAG2
2 muscle cell cellular homeostasis GO:0046716 8.96 GAA LAMP2
3 macroautophagy GO:0016236 8.8 PIK3R4 PRKAG2 VPS4A

Sources for Danon Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....